Wolf H - Search Results

1

29-week doxazosin treatment in patients with symptomatic benign prostatic hyperplasia. A double-blind placebo-controlled study.

Bendix Holme J, Christensen MM, Rasmussen PC, Jacobsen F, Nielsen J, Nørgaard JP, Olesen S, Noer I, Wolf H, Elkjaer Husted S. Bendix Holme J, et al. Among authors: wolf h. Scand J Urol Nephrol. 1994 Mar;28(1):77-82. doi: 10.3109/00365599409180475. Scand J Urol Nephrol. 1994. PMID: 7516576 Clinical Trial.

2

Doxazosin treatment in patients with prostatic obstruction. A double-blind placebo-controlled study.

Christensen MM, Bendix Holme J, Rasmussen PC, Jacobsen F, Nielsen J, Nørgaard JP, Olesen S, Noer I, Wolf H, Husted SE. Christensen MM, et al. Among authors: wolf h. Scand J Urol Nephrol. 1993;27(1):39-44. doi: 10.3109/00365599309180412. Scand J Urol Nephrol. 1993. PMID: 7684157 Clinical Trial.

3

Microsatellite alterations in urinary sediments from patients with cystitis and bladder cancer.

Christensen M, Wolf H, Orntoft TF. Christensen M, et al. Among authors: wolf h. Int J Cancer. 2000 Mar 1;85(5):614-7. doi: 10.1002/(sici)1097-0215(20000301)85:5<614::aid-ijc3>3.0.co;2-d. Int J Cancer. 2000. PMID: 10699938

4

Initial experience with percutaneous nephrolithotomy: results, problems and complications.

Petersen SE, Olesen S, Jørgensen TM, Wolf H. Petersen SE, et al. Among authors: wolf h. Scand J Urol Nephrol Suppl. 1987;104:145-50. Scand J Urol Nephrol Suppl. 1987. PMID: 3481463

5

Pronounced microsatellite instability in transitional cell carcinomas from young patients with bladder cancer.

Christensen M, Jensen MA, Wolf H, Orntoft TF. Christensen M, et al. Among authors: wolf h. Int J Cancer. 1998 Aug 21;79(4):396-401. doi: 10.1002/(sici)1097-0215(19980821)79:4<396::aid-ijc15>3.0.co;2-3. Int J Cancer. 1998. PMID: 9699533

6

Natural history of carcinoma in situ of the urinary bladder.

Wolf H, Melsen F, Pedersen SE, Nielsen KT. Wolf H, et al. Scand J Urol Nephrol Suppl. 1994;157:147-51. Scand J Urol Nephrol Suppl. 1994. PMID: 7939446

7

Allelic deletions of Rb and L-myc in urine sediments from patients with bladder tumors or carcinoma in situ.

Primdahl H, von der Maase H, Christensen M, Wolf H, Ørntoft TF. Primdahl H, et al. Among authors: wolf h. Oncol Rep. 2002 May-Jun;9(3):551-5. Oncol Rep. 2002. PMID: 11956626

8

Allelic deletions of cell growth regulators during progression of bladder cancer.

Primdahl H, von der Maase H, Christensen M, Wolf H, Orntoft TF. Primdahl H, et al. Among authors: wolf h. Cancer Res. 2000 Dec 1;60(23):6623-9. Cancer Res. 2000. PMID: 11118045

9

Rationals for optimizing bladder cancer treatment and control.

Wolf H. Wolf H. Scand J Urol Nephrol Suppl. 1989;125:103-6. Scand J Urol Nephrol Suppl. 1989. PMID: 2699070 Review.

10

Transabdominal ultrasonography plus urine cytology in control of benign bladder tumours.

Petersen SE, Lundbeck F, Brandsborg O, Steensskov V, Siem-Jørgensen P, Harving N, Wolf H. Petersen SE, et al. Among authors: wolf h. Scand J Urol Nephrol Suppl. 1989;125:121-5. Scand J Urol Nephrol Suppl. 1989. PMID: 2699073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,209 results

Search Page

Filters